Detalles de la búsqueda
1.
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study).
Diabetes Obes Metab
; 26(3): 961-970, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073422
2.
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.
Diabetes Obes Metab
; 24(3): 391-401, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704329
3.
Factors with remission of fatty liver in patients with type 2 diabetes treated with ipragliflozin.
Endocr J
; 66(11): 995-1000, 2019 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292303
4.
Factors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism.
Endocr J
; 64(4): 387-392, 2017 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28260701
5.
Improvement of ß-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis.
J Clin Endocrinol Metab
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38695547
6.
Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function.
Sci Rep
; 12(1): 9740, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35697838
7.
Dipeptidyl peptidase-4 inhibitor might exacerbate Graves' disease: A multicenter observational case-control study.
J Diabetes Investig
; 12(11): 1978-1982, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33998766
8.
Glucokinase is required for high-starch diet-induced ß-cell mass expansion in mice.
J Diabetes Investig
; 12(9): 1545-1554, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33638884
9.
Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing ß-Cell Mass in db/db Mice.
Diabetes
; 70(4): 917-931, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33608422
10.
Initial dip predicts renal protective effects after the administration of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease with normoalbuminuria.
J Clin Transl Endocrinol
; 22: 100244, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318949
11.
The Association of Cardio-Ankle Vascular Index and Ankle-Brachial Index with Macroangiopathy in Patients with Type 2 Diabetes Mellitus.
J Atheroscler Thromb
; 26(7): 616-623, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30487347
12.
Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.
Metabolism
; 98: 27-36, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31202833
13.
Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes.
J Diabetes Investig
; 10(2): 429-438, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30136403
14.
Effect of the sodium-glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages.
Sci Rep
; 8(1): 6864, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29717223
15.
The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice.
Metabolism
; 85: 48-58, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29544862
Resultados
1 -
15
de 15
1
Próxima >
>>